The Oncology Institute, Inc. (TOI) Tops Q4 EPS by 5c, Offers Guidance

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q4 EPS of ($0.15), $0.05 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $71.4 million versus the consensus estimate of $64.73 million.

GUIDANCE:

The Oncology Institute, Inc. sees FY2023 revenue of $290-320 million, versus the consensus of $309 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.

You May Also Be Interested In

• Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
• Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
• BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18